Comprehensive assessment of targetable driver alterations in lung adenocarcinomas using a clinical, hybrid capture-based, next-generation sequencing assay Meeting Abstract


Authors: Arcila, M.; Zehir, A.; Cheng, D.; Yu, H.; Kris, M.; Drilon, A.; Riely, G.; Berger, M.; Ladanyi, M.
Abstract Title: Comprehensive assessment of targetable driver alterations in lung adenocarcinomas using a clinical, hybrid capture-based, next-generation sequencing assay
Meeting Title: 104th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP)
Journal Title: Laboratory Investigation
Volume: 95
Issue: Suppl. 1
Meeting Dates: 2015 Mar 21-27
Meeting Location: Boston, MA
ISSN: 0023-6837
Publisher: Nature Publishing Group  
Date Published: 2015-02-01
Start Page: 511A
Language: English
ACCESSION: WOS:000348948003551
PROVIDER: wos
DOI: 10.1038/labinvest.2015.26
Notes: Meeting Abstract: 2052 -- 104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology -- MAR 21-27, 2015 -- Boston, MA -- 1 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Helena Alexandra Yu
    288 Yu
  2. Marc Ladanyi
    1332 Ladanyi
  3. Gregory J Riely
    604 Riely
  4. Ahmet Zehir
    345 Zehir
  5. Michael Forman Berger
    769 Berger
  6. Maria Eugenia Arcila
    669 Arcila
  7. Mark Kris
    872 Kris
  8. Alexander Edward Drilon
    636 Drilon
  9. Donavan Tai Suan Cheng
    52 Cheng